Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 200,000 shares at $2.50 ($500K) on 2018-05-15, disclosed to the SEC on 2018-05-16.
Open-market sale of $500k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 100,000 | $250K | 50.0% |
| 2 | $2.50 | 100,000 | $250K | 50.0% |
| Total | $2.50 avg | 200,000 | $500K | 100% |
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |